In Response to: 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?' by Ostler et al. and 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No' by Macbeth and Hughes-Davies

Affiliations

• ¹ Edinburgh Cancer Centre, Edinburgh, UK; Edinburgh Cancer Research UK Centre, Edinburgh, UK. Electronic address: [email protected].
• ² Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada.
• ³ Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
• ⁴ Edinburgh Cancer Centre, Edinburgh, UK; Edinburgh Cancer Research UK Centre, Edinburgh, UK.